Illinois Municipal Retirement Fund Acquires 1,109 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Illinois Municipal Retirement Fund increased its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 2.1% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 53,176 shares of the company’s stock after buying an additional 1,109 shares during the quarter. Illinois Municipal Retirement Fund’s holdings in Henry Schein were worth $3,682,000 at the end of the most recent reporting period.

Other hedge funds have also added to or reduced their stakes in the company. WD Rutherford LLC acquired a new stake in shares of Henry Schein during the fourth quarter worth $62,000. Compagnie Lombard Odier SCmA acquired a new stake in shares of Henry Schein in the first quarter valued at about $83,000. First Horizon Advisors Inc. increased its position in shares of Henry Schein by 1,087.4% in the fourth quarter. First Horizon Advisors Inc. now owns 1,318 shares of the company’s stock valued at $88,000 after acquiring an additional 1,207 shares during the last quarter. Vantage Consulting Group Inc acquired a new stake in shares of Henry Schein in the fourth quarter valued at about $116,000. Finally, Montag A & Associates Inc. acquired a new position in Henry Schein during the fourth quarter worth approximately $134,000. 94.73% of the stock is owned by hedge funds and other institutional investors.

Shares of NASDAQ HSIC opened at $74.01 on Tuesday. Henry Schein, Inc. has a fifty-two week low of $49.83 and a fifty-two week high of $74.89. The stock has a market cap of $10.53 billion, a price-to-earnings ratio of 18.23, a PEG ratio of 3.12 and a beta of 0.86. The company has a debt-to-equity ratio of 0.14, a quick ratio of 0.92 and a current ratio of 1.49. The firm’s 50-day simple moving average is $69.70 and its 200 day simple moving average is $67.35.

Henry Schein (NASDAQ:HSIC) last posted its earnings results on Tuesday, February 16th. The company reported $1.00 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.99 by $0.01. Henry Schein had a net margin of 6.14% and a return on equity of 11.60%. The firm had revenue of $3.17 billion for the quarter, compared to analysts’ expectations of $2.86 billion. During the same quarter last year, the firm earned $0.97 EPS. On average, sell-side analysts predict that Henry Schein, Inc. will post 2.93 EPS for the current year.

In other news, Director Deborah Derby bought 760 shares of the company’s stock in a transaction on Wednesday, February 24th. The shares were purchased at an average price of $66.22 per share, with a total value of $50,327.20. The purchase was disclosed in a document filed with the SEC, which can be accessed through this link. 1.05% of the stock is owned by company insiders.

A number of equities analysts have weighed in on the company. TheStreet downgraded Henry Schein from a “b” rating to a “c+” rating in a research report on Thursday, February 25th. Zacks Investment Research downgraded Henry Schein from a “buy” rating to a “hold” rating and set a $77.00 target price on the stock. in a research report on Friday. Barrington Research upped their target price on Henry Schein from $72.00 to $80.00 and gave the company an “outperform” rating in a research report on Thursday, February 18th. Piper Sandler reiterated an “overweight” rating and issued a $83.00 price target on shares of Henry Schein in a research note on Monday, February 8th. Finally, Robert W. Baird upgraded Henry Schein from a “neutral” rating to an “outperform” rating and boosted their price target for the company from $70.00 to $79.00 in a research note on Monday, January 4th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and three have issued a buy rating to the company. Henry Schein has an average rating of “Hold” and an average price target of $71.50.

About Henry Schein

Henry Schein, Inc engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution, and Technology and Value-Added Services segments. The Healthcare Distribution segment includes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.

Further Reading: What is a blue-chip stock?

Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.